S'abonner

Antenatal imaging and clinical outcome in congenital CMV infection: A field-wide systematic review and meta-analysis - 20/03/20

Doi : 10.1016/j.jinf.2020.02.012 
Aikaterini Kyriakopoulou a, , Stylianos Serghiou b, c, Dimitra Dimopoulou a, Ioli Arista d, Theodora Psaltopoulou e, Argyrios Dinopoulos a, Vassiliki Papaevangelou a
a Third Department of Paediatrics, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens 115 27, Greece 
b Department of Epidemiology and Population Health, Stanford School of Medicine, Stanford University, Stanford, CA, United States 
c Meta-Research Innovation Center at Stanford, Stanford University, Stanford, CA, United States 
d Health Economist, Independent Researcher, Athens, Greece 
e Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens 115 27, Greece 

Corresponding author.

Highlights

Fetal US and MRI are complimentary to each other with regards to predicting clinical outcome of congenitally infected fetuses.
The combination of normal fetal US and MRI in cases of congenital CMV infection have a high negative predictive value for poor postnatal clinical outcome and can be used to reassure worrying parents.
Only fetal microcephaly was shown to be strongly correlated to poor clinical outcome. This is a strong message that in most cases findings in fetal MRI are not sufficient to support TOP.
Studies display significant heterogeneity, making it difficult to compare and analyze data, highlighting the need of consensus regarding fetal imaging in pregnancies with suspected or confirmed congenital CMV.
Increased awareness, high levels of suspicion and clinical follow up by specialists are mandatory to minimize the detrimental effects caused by congenital CMV.

Le texte complet de cet article est disponible en PDF.

Abstract

Objectives

Postnatal outcome in fetuses with congenital cytomegalovirus infection (cCMV) varies from asymptomatic infection to severe neurodevelopmental impairment. Αntenatal biomarkers of long-term clinical outcome, have yet to be established. Α systematic review and meta-analysis was performed to examine whether prenatal cerebral ultrasonography (US) and magnetic resonance imaging (MRI) findings in cCMV fetuses may predict clinical outcome.

Methods

PubMed and the Web of Science were systematically searched to identify studies reporting on any prenatal US and/or MRI imaging of fetuses with cCMV as well as their postnatal clinical outcome. All reported associations between imaging and postnatal clinical outcome were systematically extracted. Where appropriate, the reported associations were quantitatively synthesized within Bayesian random-effects meta-analyses.

Results

A total of 1336 studies were screened to identify 26 eligible observational studies. Overall, 4181 fetuses were studied, of which 1518 had been diagnosed with cCMV. All studies performed fetal US while in 14 (54%) MRI was also performed. Studies substantially varied in timing of fetal imaging, reporting of abnormalities, definition of poor outcome and statistical analysis. Among studies reporting on statistical significance, 6/6 for US and 3/4 for MRI identified significant associations between imaging findings and outcome. In our meta-analyses, within isolated abnormalities, only microcephaly had greater than 95% probability of being associated with poor outcome (OR 26.7; 95% CI, 1.44–1464.5; I2, 19%). Effect sizes for US were higher than those for MRI findings.

Conclusions

Although studies displayed significant heterogeneity in both methodology and analytical decisions, it became evident that when both prenatal cerebral US and MRI are normal the negative predictive value of poor outcome is high. This is important for clinicians when consulting pregnant women. Need to standardize practices and definitions become evident.

Funding

There was no source of funding.

Le texte complet de cet article est disponible en PDF.

Keywords : Congenital CMV, Prenatal imaging, Biomarkers, Prognostic tool, Fetal MRI, Fetal US, Clinical outcome


Plan


© 2020  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 80 - N° 4

P. 407-418 - avril 2020 Retour au numéro
Article précédent Article précédent
  • Characteristics of COVID-19 infection in Beijing
  • Sijia Tian, Nan Hu, Jing Lou, Kun Chen, Xuqin Kang, Zhenjun Xiang, Hui Chen, Dali Wang, Ning Liu, Dong Liu, Gang Chen, Yongliang Zhang, Dou Li, Jianren Li, Huixin Lian, Shengmei Niu, Luxi Zhang, Jinjun Zhang
| Article suivant Article suivant
  • Cerebrospinal fluid immunoglobulins are increased in neonates exposed to Zika virus during foetal life
  • Gustavo C. Nascimento-Carvalho, Eduardo C. Nascimento-Carvalho, Martijn M. VanDuijn, Clara L. Ramos, Ana-Luisa Vilas-Boas, Otávio A. Moreno-Carvalho, Lona Zeneyedpour, Gerben Ferwerda, Ronald de Groot, Theo M. Luider, Cristiana M. Nascimento-Carvalho

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.